Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats

Neuroscience Letters

Volumn 348, Issue 3, 2003, Pages 147-150

  Feifel, David ^a   Shilling, Paul D ^a   Kuczenski, Ronald ^a   Segal, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Caudate putamen; Cholecystokinin; Cholecystokinin A receptors; Cocaine; Dopamine; Long Evans Tokushimo Otsuka; Microdialysis; Nucleus accumbens; Otsuka Long Evans Tokushima Fatty

Indexed keywords

AMPHETAMINE DERIVATIVE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; GENE MUTATION; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; RAT STRAIN; REGULATORY MECHANISM;

EID: 0042155805     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00767-5     Document Type: Article

References (20)

1. Altar C.A., Boyar W.C., Oei E., Wood P.L. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release. Brain Res. 460:1988;76-82.
2. Beinfeld M.C., Connolly K., Pierce R.C. OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats. Peptides. 22:2001;1285-1290.
3. Chiodo L.A., Freeman A.S., Bunney B.S. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide. Brain Res. 410:1987;205-211.
4. Crawley J.N. Cholecystokinin-dopamine interactions. Trends Pharmacol. Sci. 12:1991;232-236.
5. Davidowa H., Wetzel K., Henklein P. Neostriatal neurons of rats can be influenced by cholecystokinin-A receptor agonists. Neuropeptides. 31:1997;231-235.
6. Feifel D., Priebe K., Shilling P.D. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology. 24:(6):2001;663-670.
7. Graham W.C., Hill D.R., Woodruff G.N., Sambrook M.A., Crossman A.R. Reduction of [125I] Bolton Hunter CCK8 and [3H] MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey. Neurosci. Lett. 131:1991;129-134.
8. Hill D.R., Campbell N.J., Shaw T.M., Woodruff G.N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7:1987;2967-2976.
9. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature. 285:1980;476-478.
10. Hommer D.W., Palkovits M., Crawley J.N., Paul S.M., Skirboll L.R. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components. J. Neurosci. 5:1985;1387-1392.
11. Kariya K., Tanaka J., Nomura M. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res. 657:1994;1-6.
12. Kelland M.D., Zhang J., Chiodo L.A., Freeman A.S. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons. Synapse. 8:1991;137-143.
13. Kihara T., Ikeda M., Matsubara K., Matsushita A. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat. Eur. J. Pharmacol. 230:1993;271-277.
14. Kobayashi S., Ohta M., Miyasaka K., Funakoshi A. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci. Lett. 214:1996;61-64.
15. Kuczenski R., Segal D.S., Aizenstein M.L. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11:1991;2703-2712.
16. Marshall F.H., Barnes S., Hughes J., Woodruff G.N., Hunter J.C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J. Neurochem. 56:1991;917-922.
17. Rakovska A. Cholecystokinin octapeptide modulates dopamine release in rat striatum. Neurosci. Lett. 195:1995;151-154.
18. Schalling M., Friberg K., Seroogy K. Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and humans with schizophrenia. Proc. Natl. Acad. Sci. USA. 87:1990;8427-8431.
19. Shilling P.D., Feifel D. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors. Synapse. 43:2002;134-138.
20. Woodruff G.N., Hill D.R., Boden P., Pinnock R., Singh L., Hughes J. Functional role of brain CCK receptors. Neuropeptides. 19:(Suppl.):1991;45-56.